{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T06:52:02Z","timestamp":1781765522111,"version":"3.54.5"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,17]]},"DOI":"10.7759\/cureus.111063","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T06:02:44Z","timestamp":1781762564000},"source":"Crossref","is-referenced-by-count":0,"title":["Continuous Infusion and Sequential Nephron Blockade Versus Bolus Furosemide in Acute Heart Failure: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Leena Awad Alkareem","family":"Ahmed Mohamed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Abozaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hala Fakhri","family":"MohammedAhmed Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasir","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nibras Elfatih","family":"Hussein Abdalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Samir Yasin","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weam Mohammed","family":"Ahmed Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Mohammed","family":"Babikir Omer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa","family":"Awad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-0151-7","article-title":"Acute heart failure","volume":"6","author":"Arrigo M","year":"2020","unstructured":"Arrigo M, Jessup M, Mullens W, Reza N, Shah AM, Sliwa K, Mebazaa A. Acute heart failure. Nat Rev Dis Primers. 2020, 6:16. 10.1038\/s41572-020-0151-7","journal-title":"Nat Rev Dis Primers"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/medicina60010133","article-title":"Clinical review of hypertensive acute heart failure","volume":"60","author":"Lasica R","year":"2024","unstructured":"Lasica R, Djukanovic L, Vukmirovic J, Zdravkovic M, Ristic A, Asanin M, Simic D. Clinical review of hypertensive acute heart failure. Medicina (Kaunas). 2024, 60:10.3390\/medicina60010133","journal-title":"Medicina (Kaunas)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13020311","article-title":"Decongestion in acute heart failure\u2014time to rethink and standardize current clinical practice?","volume":"13","author":"Bilgeri V","year":"2024","unstructured":"Bilgeri V, Spitaler P, Puelacher C, et al.. Decongestion in acute heart failure\u2014time to rethink and standardize current clinical practice?. J Clin Med. 2024, 13:10.3390\/jcm13020311","journal-title":"J Clin Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fneph.2022.879766","article-title":"New insights into diuretic use to treat congestion in the ICU: beyond furosemide","volume":"2","author":"Escudero VJ","year":"2022","unstructured":"Escudero VJ, Mercadal J, Molina-And\u00fajar A, et al.. New insights into diuretic use to treat congestion in the ICU: beyond furosemide. Front Nephrol. 2022, 2:879766. 10.3389\/fneph.2022.879766","journal-title":"Front Nephrol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD014811.pub2","article-title":"Continuous infusion versus bolus injection of loop diuretics for acute heart failure","volume":"5","author":"Rasoul D","year":"2024","unstructured":"Rasoul D, Zhang J, Farnell E, et al.. Continuous infusion versus bolus injection of loop diuretics for acute heart failure. Cochrane Database Syst Rev. 2024, 5:CD014811. 10.1002\/14651858.CD014811.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-024-00918-x","article-title":"Diuretics in patients with chronic kidney disease","volume":"21","author":"Agarwal R","year":"2025","unstructured":"Agarwal R, Verma A, Georgianos PI. Diuretics in patients with chronic kidney disease. Nat Rev Nephrol. 2025, 21:264-78. 10.1038\/s41581-024-00918-x","journal-title":"Nat Rev Nephrol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jjcc.2024.06.005","article-title":"Treatment strategies for diuretic resistance in patients with heart failure","volume":"85","author":"Horiuchi Y","year":"2025","unstructured":"Horiuchi Y, Wettersten N. Treatment strategies for diuretic resistance in patients with heart failure. J Cardiol. 2025, 85:1-7. 10.1016\/j.jjcc.2024.06.005","journal-title":"J Cardiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/emermed-2020-209567","article-title":"Population, Intervention, Comparison, Outcomes and Study (PICOS) design as a framework to formulate eligibility criteria in systematic reviews","volume":"37","author":"Amir-Behghadami M","year":"2020","unstructured":"Amir-Behghadami M, Janati A. Population, Intervention, Comparison, Outcomes and Study (PICOS) design as a framework to formulate eligibility criteria in systematic reviews. Emerg Med J. 2020, 37:387. 10.1136\/emermed-2020-209567","journal-title":"Emerg Med J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne JA","year":"2019","unstructured":"Sterne JA, Savovi\u0107 J, Page MJ, et al.. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019, 366:l4898. 10.1136\/bmj.l4898","journal-title":"BMJ"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne JA","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, et al.. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016, 355:i4919. 10.1136\/bmj.i4919","journal-title":"BMJ"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2025.05.026","article-title":"Different loop diuretic dosing and administration in acute heart failure (DIUR-AHF): a multicenter prospective observational open-label study","volume":"138","author":"Palazzuoli A","year":"2025","unstructured":"Palazzuoli A, Pirrotta F, Stefanini A, et al.. Different loop diuretic dosing and administration in acute heart failure (DIUR-AHF): a multicenter prospective observational open-label study. Eur J Intern Med. 2025, 138:121-8. 10.1016\/j.ejim.2025.05.026","journal-title":"Eur J Intern Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2024.02.009","article-title":"Efficacy and safety of dapagliflozin in patients with acute heart failure","volume":"83","author":"Cox ZL","year":"2024","unstructured":"Cox ZL, Collins SP, Hernandez GA, et al.. Efficacy and safety of dapagliflozin in patients with acute heart failure. J Am Coll Cardiol. 2024, 83:1295-306. 10.1016\/j.jacc.2024.02.009","journal-title":"J Am Coll Cardiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/clc.70033","article-title":"Outcomes of bolus dose furosemide versus continuous infusion in patients with acute decompensated left ventricular failure and atrial fibrillation","volume":"47","author":"Khan B","year":"2024","unstructured":"Khan B, Shuja D, Saqib BU, et al.. Outcomes of bolus dose furosemide versus continuous infusion in patients with acute decompensated left ventricular failure and atrial fibrillation. Clin Cardiol. 2024, 47:e70033. 10.1002\/clc.70033","journal-title":"Clin Cardiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad341","article-title":"Dapagliflozin vs. metolazone in heart failure resistant to loop diuretics","volume":"44","author":"Yeoh SE","year":"2023","unstructured":"Yeoh SE, Osmanska J, Petrie MC, et al.. Dapagliflozin vs. metolazone in heart failure resistant to loop diuretics. Eur Heart J. 2023, 44:2966-77. 10.1093\/eurheartj\/ehad341","journal-title":"Eur Heart J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s43054-023-00225-3","article-title":"Furosemide continuous infusion versus repeated injection in the management of acute decompensated heart failure in infants with left to right shunt: a randomized trial","author":"Zarzor M","year":"2023","unstructured":"Zarzor M, Hasaneen B, Abouelkheir MM, El-Halaby H. Furosemide continuous infusion versus repeated injection in the management of acute decompensated heart failure in infants with left to right shunt: a randomized trial. Egyptian Pediatric Association Gazette. 2023, 77. 10.1186\/s43054-023-00225-3","journal-title":"Egyptian Pediatric Association Gazette"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac689","article-title":"Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial","volume":"44","author":"Trull\u00e0s JC","year":"2023","unstructured":"Trull\u00e0s JC, Morales-Rull JL, Casado J, et al.. Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial. Eur Heart J. 2023, 44:411-21. 10.1093\/eurheartj\/ehac689","journal-title":"Eur Heart J"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.122.059038","article-title":"Effects of early empagliflozin initiation on diuresis and kidney function in patients with acute decompensated heart failure (EMPAG-HF)","volume":"146","author":"Schulze PC","year":"2022","unstructured":"Schulze PC, Bogoviku J, Westphal J, et al.. Effects of early empagliflozin initiation on diuresis and kidney function in patients with acute decompensated heart failure (EMPAG-HF). Circulation. 2022, 146:289-98. 10.1161\/CIRCULATIONAHA.122.059038","journal-title":"Circulation"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2203094","article-title":"Acetazolamide in acute decompensated heart failure with volume overload","volume":"387","author":"Mullens W","year":"2022","unstructured":"Mullens W, Dauw J, Martens P, et al.. Acetazolamide in acute decompensated heart failure with volume overload. N Engl J Med. 2022, 387:1185-95. 10.1056\/NEJMoa2203094","journal-title":"N Engl J Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-96002-6","article-title":"Effect of adding hydrochlorothiazide to usual treatment of patients with acute decompensated heart failure: a randomized clinical trial","volume":"11","author":"Piardi DS","year":"2021","unstructured":"Piardi DS, Butzke M, Mazzuca AC, et al.. Effect of adding hydrochlorothiazide to usual treatment of patients with acute decompensated heart failure: a randomized clinical trial. Sci Rep. 2021, 11:16474. 10.1038\/s41598-021-96002-6","journal-title":"Sci Rep"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.13286","article-title":"Continuous versus intermittent use of furosemide in patients with heart failure and moderate chronic renal dysfunction","volume":"8","author":"Zheng Z","year":"2021","unstructured":"Zheng Z, Jiang X, Chen J, He D, Xie X, Lu Y. Continuous versus intermittent use of furosemide in patients with heart failure and moderate chronic renal dysfunction. ESC Heart Fail. 2021, 8:2070-8. 10.1002\/ehf2.13286","journal-title":"ESC Heart Fail"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1005419","article-title":"Diuretic strategies in patients with acute decompensated heart failure","volume":"364","author":"Felker GM","year":"2011","unstructured":"Felker GM, Lee KL, Bull DA, et al.. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med. 2011, 364:797-805. 10.1056\/NEJMoa1005419","journal-title":"N Engl J Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray JJ","year":"2019","unstructured":"McMurray JJ, Solomon SD, Inzucchi SE, et al.. Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med. 2019, 381:1995-2008. 10.1056\/NEJMoa1911303","journal-title":"N Engl J Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.12.059","article-title":"Diuretic therapy for patients with heart failure: JACC state-of-the-art review","volume":"75","author":"Felker GM","year":"2020","unstructured":"Felker GM, Ellison DH, Mullens W, Cox ZL, Testani JM. Diuretic therapy for patients with heart failure: JACC state-of-the-art review. J Am Coll Cardiol. 2020, 75:1178-95. 10.1016\/j.jacc.2019.12.059","journal-title":"J Am Coll Cardiol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.11.084","article-title":"Renal impairment and outcomes in heart failure: systematic review and meta-analysis","volume":"47","author":"Smith GL","year":"2006","unstructured":"Smith GL, Lichtman JH, Bracken MB, Shlipak MG, Phillips CO, DiCapua P, Krumholz HM. Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol. 2006, 47:1987-96. 10.1016\/j.jacc.2005.11.084","journal-title":"J Am Coll Cardiol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare10122356","article-title":"SGLT2 inhibitors in acute heart failure: a meta-analysis of randomized controlled trials","volume":"10","author":"Ul Amin N","year":"2022","unstructured":"Ul Amin N, Sabir F, Amin T, Sarfraz Z, Sarfraz A, Robles-Velasco K, Cherrez-Ojeda I. SGLT2 inhibitors in acute heart failure: a meta-analysis of randomized controlled trials. Healthcare (Basel). 2022, 10:10.3390\/healthcare10122356","journal-title":"Healthcare (Basel)"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.04.021","article-title":"Abnormalities of potassium in heart\u00a0failure: JACC state-of-the-art review","volume":"75","author":"Ferreira JP","year":"2020","unstructured":"Ferreira JP, Butler J, Rossignol P, et al.. Abnormalities of potassium in heart\u00a0failure: JACC state-of-the-art review. J Am Coll Cardiol. 2020, 75:2836-50. 10.1016\/j.jacc.2020.04.021","journal-title":"J Am Coll Cardiol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2019.09.012","article-title":"Diuretic strategies for loop diuretic resistance in acute heart failure: the 3T trial","volume":"8","author":"Cox ZL","year":"2020","unstructured":"Cox ZL, Hung R, Lenihan DJ, Testani JM. Diuretic strategies for loop diuretic resistance in acute heart failure: the 3T trial. JACC Heart Fail. 2020, 8:157-68. 10.1016\/j.jchf.2019.09.012","journal-title":"JACC Heart Fail"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/501511-continuous-infusion-and-sequential-nephron-blockade-versus-bolus-furosemide-in-acute-heart-failure-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T06:02:45Z","timestamp":1781762565000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/501511-continuous-infusion-and-sequential-nephron-blockade-versus-bolus-furosemide-in-acute-heart-failure-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.111063","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,17]]}}}